Smad7 mediates inhibition of Saos2 osteosarcoma cell differentiation by NFκB

Experimental Cell Research

Volumn 312, Issue 1, 2006, Pages 40-50

  Eliseev, Roman A ^a   Schwarz, Edward M ^a   Zuscik, Michael J ^a   O'Keefe, Regis J ^a   Drissi, Hicham ^a   Rosier, Randy N ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

BMP; NF B; Osteoblasts; Osteosarcoma; Saos2; Smad7

Indexed keywords

ALKALINE PHOSPHATASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SMAD7 PROTEIN; TRANSCRIPTION FACTOR RUNX1; TRANSCRIPTION FACTOR RUNX2;

APOPTOSIS; ARTICLE; BONE CELL; CELL DIFFERENTIATION; CELL FATE; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; OSTEOBLAST; OSTEOSARCOMA; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 27944463205     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2005.09.016     Document Type: Article

References (33)

1. B. Rayet, and C. Gelinas Aberrant rel/nfkb genes and activity in human cancer Oncogene 18 1999 6938 6947
2. P.J. Barnes Nuclear factor-κB Int. J. Biochem. Cell Biol. 29 1997 867 870
3. F.R. Greten, and M. Karin The IKK/NF-kB activation pathway-A target for prevention and treatment of cancer Cancer Lett. 206 2004 193 199
4. A. Israel, O. Le Bail, D. Hatat, J. Piette, M. Kieran, F. Logeat, D. Wallach, M. Fellous, and P. Kourilsky TNF stimulates expression of mouse MHC class I genes by inducing an NF kappa B-like enhancer binding activity which displaces constitutive factors EMBO J. 8 1989 3793 3800
5. R. Sen, and D. Baltimore Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism Cell 47 1986 921 928
6. L. Osborn, S. Kunkel, and G.J. Nabel Tumor Necrosis Factor α and Interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor κB Proc. Natl. Acad. Sci. U. S. A. 86 1989 2336 2340
7. B. Stein, M. Kramer, H.J. Rahmsdorf, H. Ponta, and P. Herrlich UV-induced transcription from the human immunodeficiency virus type 1 (HIV-1) long terminal repeat and UV-induced secretion of an extracellular factor that induces HIV-1 transcription in nonirradiated cells J. Virol. 63 1989 4540 4544
8. T.J. Novak, D. Chen, and E.V. Rothenberg Interleukin-1 synergy with phosphoinositide pathway agonists for induction of interleukin-2 gene expression: molecular basis of costimulation Mol. Cell. Biol. 10 1990 6325 6334
9. S. Ghosh, M.J. May, and E.B. Kopp NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses Annu. Rev. Immunol. 16 1998 225 260
10. V.B. Andela, T.J. Sheu, E.J. Puzas, E.M. Schwarz, R.J. O'Keefe, and R.N. Rosier Malignant reversion of a human osteosarcoma cell line, Saos-2, by inhibition of NFκB Bioch. Biophys. Res. Commun. 297 2002 237 241
11. D. Chen, M. Zhao, and G.R. Mundy Bone morphogenetic proteins Growth Factors 22 2004 233 241
12. Y. Shi, and J. Massague Mechanisms of TGF-beta signaling from cell membrane to the nucleus Cell 113 2003 685 700
13. G.S. Stein, J.B. Lian, A.J. van Wijnen, J.L. Stein, M. Montecino, A. Javed, D.W. S.K.Zaidi, J.Y. Young, and S.M. Choi Runx2 control of organization, assembly and activity of the regulatory machinery for skeletal gene expression Oncogene 23 2004 4315 4329
14. E. Balint, D. Lapointe, H. Drissi, C. van der Meijden, D.W. Young, A.J. van Wijnen, J.L. Stein, G.S. Stein, and J.B. Lian Phenotype discovery by gene expression profiling: mapping of biological processes linked to BMP-2-mediated osteoblast differentiation J. Cell. Biochem. 89 2003 401 426
15. J. Pratap, M. Galindo, S.K. Zaidi, D. Vradii, B.M. Bhat, J.A. Robinson, J.Y. Choi, T. Komori, J.L. Stein, J.B. Lian, G.S. Stein, and A.J. van Wijnen Cell growth regulatory role of Runx2 during proliferative expansion of preosteoblasts Cancer Res. 63 2003 5357 5362
16. E. Hay, J. Lemonnier, O. Fromigue, and P.J. Marie Bone morphogenetic protein-2 promotes osteoblast apoptosis through a Smad-independent, protein kinase C-dependent signaling pathway J. Biol. Chem. 276 2001 29028 29036
17. E. Hay, J. Lemonnier, O. Fromigue, H. Guenou, and P.J. Marie Bone morphogenetic protein receptor IB signaling mediates apoptosis independently of differentiation in osteoblastic cells J. Biol. Chem. 279 2004 1650 1658
18. L. Ulloa, J. Doody, and J. Massague Inhibition of transforming growth factor-β/SMAD signalling by the interferon-γ/STAT pathway Nature 397 1999 710 713
19. A. Ionescu, H. Drissi, E.M. Schwarz, M. Kato, J.E. Puzas, D.J. McCance, R.N. Rosier, M.J. Zuscik, and R.J. O'Keefe CREB cooperates with BMP-stimulated Smad signaling to enhance transcription of the Smad6 promoter J. Cell. Physiol. 198 2004 428 440
20. A. Hata, G. Lagna, J. Massague, and A. Hemmati-Brivanlou Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor Genes Dev. 12 1998 186 197
21. S. Souchelnytskyi, T. Nakayama, A. Nakao, A. Moren, C.H. Heldin, J.L. Christian, and P. Dijke Physical and functional interaction of murine and Xenopus Smad7 with bone morphogenetic protein receptors and transforming growth factor-beta receptors J. Biol. Chem. 273 1998 25364 25370
22. M. Zhao, M. Qiao, S.E. Harris, B.O. Oyajobi, G.R. Mundy, and D. Chen Smurf1 inhibits osteoblast differentiation and bone formation in vitro and in vivo J. Biol. Chem. 279 2004 12854 12859
23. R.P. Nagarajan, F. Chen, W. Li, E. Vig, M.A. Harrington, H. Nakshatri, and Y. Chen Repression of transforming-growth-factor-beta-mediated transcription by nuclear factor kappaB Biochem. J. 348 2000 591 596
24. M. Bitzer, G. von Gersdorff, D. Liang, A. Dominguez-Rosales, A.A. Beg, M. Rojkind, and E.P. Bottinger A mechanism of suppression of TGF-b/Smad signaling by NF-kB/RelA Genes Dev. 14 2000 187 197
25. S. Papa, F. Zazzeroni, C. Bubici, S. Jayawardena, K. Alvarez, S. Matsuda, D.U. Nguyen, C.G. Pham, A.H. Nelsbach, T. Melis, E. De Smaele, W.J. Tang, L. D'Adamio, and G. Franzoso Gadd45β mediates the NF-κB suppression of JNK signalling by targeting MKK7/JNKK2 Nat. Cell Biol. 6 2004 146 153
26. G.A. Webster, and N.D. Perkins Transcriptional cross talk between NF-kappaB and p53 Mol. Cell. Biol. 19 1999 3485 3495
27. L. Huang, X.Y. Teng, Y. Cheng, K.M. Lee, and S.M. Kumta Expression of preosteoblast markers and Cbfa-1 and Osterix gene transcripts in stromal tumour cells of giant cell tumour of bone Bone 34 2004 393 401
28. R. Grubera, W. Graningerb, K. Bobaczb, G. Watzeka, and L. Erlacher BMP-6-induced osteogenic differentiation of mesenchymal cell lines is not modulated by sex steroids and resveratrol Cytokine 23 2003 133 137
29. A.T. Raiche, and D.A. Puleo Cell responses to BMP-2 and IGF-I released with different time-dependent profiles J. Biomed. Mater. Res. 69A 2004 342 350
30. Y. Yu, R.I. Harris, J.L. Yang, H.C. Anderson, and W.R. Walsh Differential expression of osteogenic factors associated with osteoinductivity of human osteosarcoma cell lines J. Biomed. Mater. Res. 70A 2004 122 128
31. A. Nakao, M. Afrakhte, A. Morn, T. Nakayama, J.L. Christian, R. Heuchel, S. Itoh, M. Kawabata, N.E. Heldin, and C.H. Heldin P. ten Dijke, Identification of Smad7, a TGFβ-inducible antagonist of TGFβ signalling Nature 389 1997 631 635
32. H. Hayashi, S. Abdollah, Y. Qiu, J. Cai, Y.Y. Xu, B.W. Grinnell, M.A. Richardson, J.N. Topper, M.A. Gimbrone, J.L. Wrana, and D. Falb The MAD-related protein Smad7 associates with the TGFβ receptor and functions as an antagonist of TGFβ signaling Cell 89 1997 1165 1173
33. C. Kawamura, M. Kizaki, K. Yamato, H. Uchida, Y. Fukuchi, Y. Hattori, T. Koseki, T. Nishihara, and Y. Ikeda Bone morphogenetic protein-2 induces apoptosis in human myeloma cells with modulation of STAT3 Blood 96 2000 2005 2011